Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Dendreon Pharmaceuticals LLC
FDA Inspection
•Dendreon Pharmaceuticals LLC•August 10, 2023

Dendreon Pharmaceuticals LLC – FDA Inspection, Aug 10, 2023

Record Details

This FDA Inspection record concerns Dendreon Pharmaceuticals LLC, with an inspection on August 10, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Dendreon Pharmaceuticals LLC
Inspection Date
August 10, 2023
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Burnell M. Henry (FDA Associated Person)
  • Latorie S. Jones (FDA Associated Person)
  • Susan M. Jackson (Issuing Officer)
View Company Profile

ID · 4fe7a753-79ef-4ea0-be81-129f0bb9e16c

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1214688
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued

FDA Citations

4
  1. 21 CFR 211.84(e)Rejecting When Specifications Not Met
  2. 21 CFR 211.192Extent of discrepancy, failure investigations
  3. 21 CFR 211.192Extent of discrepancy, failure investigations
  4. 21 CFR 211.84(e)Rejecting When Specifications Not Met

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Dendreon Pharmaceuticals LLC

5
DateClassificationOfficeProject area
March 25, 2026Not classifiedLos Angeles District OfficeHuman Cellular, Tissue, and Gene Therapies
November 8, 2019VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
January 19, 2018VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
January 22, 2016VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
November 15, 2012VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
Other documents for Dendreon Pharmaceuticals LLC
  • FDA Inspection 1303248 - 2026-03-25
  • FDA Inspection 1109236 - 2019-11-08
  • FDA Inspection 1038072 - 2018-01-19
  • FDA Inspection 961300 - 2016-01-22
  • FDA Inspection 848259 - 2012-11-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dendreon Pharmaceuticals LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.